Seeking Alpha

  Cytokinetics, Incorporated (CYTK) - NASDAQ

  • The Scientist | Send Message 24 Jan 2013

    If $CYTK can get above the $3 level, will then start to see some real buying action from big institutional investors.
    Reply (1)
    • The Scientist | Send Message 24 Jan 2013
      : Vanguard, Fidelity, Deutsche Bank and T Rowe Price already on board as major shareholders.
      CYTK vs. ETF Alternatives
      Company Description
      Cytokinetics Inc is a clinical stage biopharmaceutical company focused on the discovery and development of novel small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States